DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR GLIPIZIDE
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
All Clinical Trials for Glipizide
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00094770 | An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-09-01 | The purpose of this investigational study is to determine the safety and effectiveness of an investigational drug in patients with type 2 diabetes mellitus (a specific type of diabetes). |
| NCT00116831 | Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes | Completed | GlaxoSmithKline | Phase 3 | 2005-01-01 | The purpose of this study is to test the safety and effectiveness of rosiglitazone against a sulfonylurea in reducing or slowing the development of atherosclerosis in the blood vessels of the heart. |
| NCT00509236 | Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2007-10-01 | The purpose of the study is to compare sitagliptin and glipizide in lowering blood sugar in participants with type-2 diabetes mellitus (T2DM) and end-stage renal disease on dialysis who do not have adequate glycemic control. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Glipizide
Condition Name
Condition MeSH
Clinical Trial Locations for Glipizide
Trials by Country
Clinical Trial Progress for Glipizide
Clinical Trial Phase
Clinical Trial Sponsors for Glipizide
Sponsor Name
